Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/17/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Timothy R. Franson

Wrong Dr. Timothy R. Franson?

Chief Medical Officer

YourEncore Inc
10925 Reed Hartman Hwy Suite 800 Suite 114
Indianapolis , Indiana 46204
United States

Company Description: YourEncore was created to tap into our country's under-utilized asset: the growing number of retired and veteran scientists. We provide an environment where these...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D.
  • M.D. degree
    University of Illinois
  • undergraduate degree , Pharmacy
    Drake University
148 Total References
Web References
Our Board of Directors currently consists ...
www.sec.gov, 21 Nov 2012 [cached]
Our Board of Directors currently consists of eight members, classified into three classes as follows: (1) Jason M. Aryeh, Timothy R. Franson, David W. Gryska and Robert J. Lollini constitute the Class I directors with a term ending at the 2013 annual meeting, however Mr. Lollini will be resigning from the Board of Directors on November 15, 2012; (2) John T. Henderson and Robert Forrester constitute the Class II directors with a term ending at the 2014 annual meeting; and (3) Gerald P. Belle and Dennis H. Langer constitute the Class III directors with a term ending at the 2012 annual meeting.
...
Timothy R. Franson, M.D. (3)
...
Timothy R. Franson, M.D., joined the Myrexis Board of Directors on September 10, 2009. Dr. Franson has served as Senior Vice President with B&D Consulting since December 2009, and now as Principal at Faegre BD Consulting (a merged firm from Faegre Benson and B&D Consulting) and served as Senior Advisor from August 2008 until December 2009. He also serves as President of the United States Pharmacopeial Convention (2010-2015) and previously served as a Director for Quadraspec, Inc., a small technology firm in West Lafayette, Indiana. Until his retirement in June 2008, Dr. Franson was with Eli Lilly and Company for over 20 years, most recently as Vice President of Global Regulatory Affairs and Drug Safety. Previous positions held at Lilly included Group Medical Director for Europe, Executive Director for North American Regulatory, Chemistry Manufacturing Control, Planning & Global Operations and Vice President of Clinical Research and Regulatory Affairs-US. Dr. Franson has served as chair of the Clinical Steering Committee and as a member of the Regulatory Affairs Coordinating Committee of the Pharmaceutical Research and Manufacturers’ Association (PhRMA) and until recently, chaired PhRMAs FDA Committee Staff Work Group (2000-2008). He was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal; and from 2000-2003 he co-chaired the overall industry-FDA committees for PDUFA-3 renewal. Dr. Franson received his undergraduate degree in Pharmacy at Drake University and his M.D. degree at the University of Illinois. He is Board Certified in Internal Medicine and Infectious Diseases and prior to joining Lilly was Assistant Professor of Medicine at the Medical College of Wisconsin where he was a member of the Governor’s Task Force on AIDS. He was also an Assistant Professor of Medicine at Indiana University School of Medicine (1987-2008) and on the Board of Directors of the National Patient Safety Foundation (2001-2006).
Our Board of Directors has concluded that Dr. Franson should serve as a director of Myrexis, Inc. due particularly to his knowledge and experience in policymaking and regulatory and compliance issues in the pharmaceutical industry in both the United States and internationally, as well as his extensive clinical and senior management experience at a large, global, publicly held pharmaceutical company.
Documents
www.myrexis.com [cached]
2009.09.15 - Myriad Pharmaceuticals Elects Timothy R. Franson, M.D. to Its Board of Directors
YourEncore Team
yourencore.com, 20 Oct 2014 [cached]
Timothy Franson, M.D. Chief Medical Officer
Dr. Tim Franson oversees the strategy and development of clinical, medical affairs and regulatory offerings after a distinguished career in health care that spans three decades. Prior to joining YourEncore, Dr. Franson was a principal in FaegreBD Consulting's health and bioscience practice and was the Vice President of Global Regulatory Affairs & Patient Safety for Lilly, where he spent 20+ years. Dr. Franson is board certified in internal medicine/ infectious diseases, currently serves as the President of the United States Pharmacopeial Convention, and is the author of 50+ scientific articles and four book chapters.
Tim Franson Receives Weaver ...
www.faegrebdc.com, 7 Feb 2013 [cached]
Tim Franson Receives Weaver Medal for Contributions to Pharmacy Profession
Related Sectors
...
Timothy R. Franson, M.D.
...
Tim Franson Receives Weaver Medal for Contributions to Pharmacy Profession
...
Washington, D.C. (07-January-2013) - Dr. Timothy Franson, principal in the health and biosciences group at FaegreBD Consulting, has been named the 2013 recipient of the Weaver Medal of Honor, the Drake University College of Pharmacy and Health Sciences' highest honor.
The Weaver Medal of Honor recognizes individuals who have impacted the profession of pharmacy and the advancement of human health.
At FaegreBD Consulting, Franson leads the regulatory affairs practice, providing pre-approval and postmarketing regulatory advice for pharmaceutical and biologics development, as well as regulatory reimbursement and media training. He also provides policy, program development and consultative support to rare disease stakeholders. He is the founder of Franson PharmAdvisors LLC, a clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting.
From 1986-2008, Franson worked with global pharmaceutical company Eli Lilly and Company, retiring as vice president of global regulatory affairs at Lilly Research Laboratories. From 1995-2008, he was directly responsible for Lilly's FDA submissions, regulatory compliance and policy matters. Prior to his career with Lilly, Franson was an attending physician and assistant professor of medicine.
Franson serves as president of the U.S. Pharmacopeia Convention and on the National Center for Advancing Translational Sciences' Therapeutics for Rare and Neglected Diseases review panel. He was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal. From 2000-03, he co-chaired industry-FDA committees for PDUFA-3 renewal. Franson also co-chaired an FDA-industry safety interventions working group, was a member of the AAMC-PhRMA Clinical Trials Forum and was a member of the Regulatory Advisory Board for the Centre for Medicines Research International from 2003-08.
Franson will receive the Weaver Medal of Honor during a ceremony on Wednesday, April 24, 2013. Franson, a 1974 graduate of Drake's pharmacy school, will deliver the annual Weaver Lecture at the ceremony, which will be held at 2 p.m. in the university's Sheslow Auditorium.
...
Timothy R. Franson, M.D.
Connect with us
InteKrin Therapeutics, Inc.
www.intekrin.com, 6 Sept 2012 [cached]
Tim Franson, M.D. Franson PharmAdvisors and B&D Consulting
Dr. Franson serves as a senior advisor in the health and life sciences sector. He has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development (small and large molecule) relating to interactions with FDA for policy and product issues, as well as interactions with global regulators.
Before joining B&D Consulting, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company), responsible for all regulatory and patient safety activities from 2003 until his retirement from Lilly in June, 2008. He joined Eli Lilly and Company in 1986. Dr. Franson previously served as Lilly's Director of Anti-Infectives Group Medical Director of Europe (based in the United Kingdom); Executive Director of Health Economics Research and Decision Sciences; and Executive Director of Regulatory Affairs responsible for North American Regulatory, Chemistry Manufacturing Control, Planning & Global Operations (safety, labeling, medical information, registration and submissions). From 1997 to 2003, Dr. Franson was Vice President of Clinical Research and Regulatory Affairs-U.S for Lilly. In regulatory affairs from 1995 to 2008, Dr. Franson was directly responsible for Lilly's FDA submissions (NDAs, supplements), which involved more than 20 major submission reviews and approvals.
Dr. Franson has been a leader in many industry initiatives. He was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal. From 2000 to 2003, he co-chaired industry-FDA committees for PDUFA-3 renewal and has testified, on behalf of industry, at several congressional hearings. Dr. Franson also co-chaired an FDA-industry safety interventions working group, was a member of the AAMC-PhRMA Clinical Trials Forum and was a member of the Regulatory Advisory Board for the Centre for Medicines Research International (2003-08).
Dr. Franson has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics and antibiotic utilization.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304